- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 1, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
OBR Daily’s featured oncology news headlines for Wednesday, October 30, included 2 articles from The American Journal of Managed Care® (AJMC®)’s coverage of the Community Oncology Alliance Payer Exchange Summit 2019: “Moving Into the Future of Cancer Care Through OCM 2.0” and “Providers Move Forward With 2-Sided Risk and Take on Pharma.”
The Wednesday OBR Daily newsletter also included an article from AJMC®’s sister site The Center for Biosimilars® titled “Pfizer Announces Launch Dates for 2 More Anticancer Biosimilars: Ruxience and Trazimera.” The article listed the dates on which the 2 anticancer biosimilars will become commercially available to the public.
An article in the Philly Voice, “Doctors, nurses are burned out on the job, does that put patients’ health at risk?” referenced a 2018 AJMC® newsroom article in its findings. The article, titled “Physician Burnout Associated With Poorer Patient Outcomes,” reported that physician burnout is associated with an increased risk of patient safety incidents, poorer quality of care, and reduced patient satisfaction.
A press release issued by MDVIP, “Three Florida Doctors Join National MDVIP Network to Provide Personalized, Preventive Primary Care,” cited a study in the December 2012 issue of AJMC®, “Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization.” The AJMC® study assessed the impact of the MDVIP personalized preventive care model on hospital utilization and found that MDVIP members’ utilizationrates were substantially lower than those of nonmembers.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
